Better together: assessing the evolving combination therapy picture in I–O

Immuno-Oncology Insights 2023; 4(4), 209–213

DOI: 10.18609/ioi.2023.027

Published: 7 June
Yisrael Katz

Roisin McGuigan, Editor, Immuno-Oncology Insights, speaks to Yisrael Katz, Senior Medical Director at Viracta Therapeutics, who shares his insights and predictions for the current and future progress of I–O combination therapy.